| Literature DB >> 36076833 |
Daniel Rodríguez-Rico1, María de Los Ángeles Sáenz-Esqueda1, Jorge Armando Meza-Velázquez1, Juan José Martínez-García1, Jesús Josafath Quezada-Rivera2, Mónica M Umaña3, Rafael Minjares-Fuentes1.
Abstract
The bioactive compounds, antioxidant capacity and microbiological quality of melon juice processed by high-intensity ultrasound (HIUS) were studied. Melon juice was processed at two ultrasound intensities (27 and 52 W/cm2) for two different processing times (10 and 30 min) using two duty cycles (30 and 75%). Unprocessed juice was taken as a control. Total carotenoids and total phenolic compounds (TPC) were the bioactive compounds analyzed while the antioxidant capacity was determined by DPPH, ABTS and FRAP assays. The microbiological quality was tested by counting the aerobic and coliforms count as well as molds and yeasts. Total carotenoids increased by up to 42% while TPC decreased by 33% as a consequence of HIUS processing regarding control juice (carotenoids: 23 μg/g, TPC: 1.1 mg GAE/g), gallic acid and syringic acid being the only phenolic compounds identified. The antioxidant capacity of melon juice was enhanced by HIUS, achieving values of 45% and 20% of DPPH and ABTS inhibition, respectively, while >120 mg TE/100 g was determined by FRAP assay. Further, the microbial load of melon juice was significantly reduced by HIUS processing, coliforms and molds being the most sensitive. Thus, the HIUS could be an excellent alternative supportive the deep-processing of melon products.Entities:
Keywords: antioxidant capacity; bioactive compounds; gallic acid; high-intensity ultrasound; melon juice; microbiological quality; syringic acid
Year: 2022 PMID: 36076833 PMCID: PMC9455593 DOI: 10.3390/foods11172648
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Figure 1Centrifugal sedimentation of control (unprocessed), pasteurized and HIUS processed melon (Cucumis melo) juice. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).
Figure 2Color change of pasteurized and HIUS processed melon (Cucumis melo) juice. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).
Figure 3Total carotenoids content of control (unprocessed), pasteurized and HIUS processed melon (Cucumis melo) juice. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).
Figure 4The total phenolic compound of control (unprocessed), pasteurized and HIUS processed melon (Cucumis melo) juice. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).
Figure 5Individual phenolic compounds identified by HPLC-DAD in control (unprocessed), pasteurized and HIUS processed melon (Cucumis melo) juice: (a) gallic acid and (b) syringic acid. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).
Antioxidant capacity of control (unprocessed), pasteurized and HIUS processed melon (Cucumis melo) juice. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).
| Melon Juice | DPPH | ABTS | FRAP | ||
|---|---|---|---|---|---|
| (%) | (%) | (mg TE/100 g dm) | |||
|
| 29.8 ± 0.9 g | 15.2 ± 1.3 e | 39.64 ± 1.5 f | ||
|
| 39.3 ± 1.0 c | 8.65 ± 1.0 f | 62.29 ± 0.8 h | ||
|
| |||||
|
|
|
| |||
|
|
|
| |||
| 27 | 10 | 30 | 33.1 ± 1.1 f | 26.0 ± 1.8 c | 89.79 ± 0.7 e |
| 75 | 30.6 ± 1.6 g | 20.1 ± 0.7 d | 56.91 ± 1.3 g | ||
| 30 | 30 | 39.5 ± 0.7 c | 28.0 ± 0.7 b | 111.7 ± 2.1 b | |
| 75 | 45.9 ± 1.0 a | 31.3 ± 0.1 a | 110.1 ± 1.9 bc | ||
| 52 | 10 | 30 | 41.8 ± 1.4 b | 30.5 ± 0.4 a | 108.7 ± 1.3 c |
| 75 | 41.5 ± 1.6 b | 31.4 ± 0.4 a | 122.4 ± 3.3 a | ||
| 30 | 30 | 37.5 ± 0.4 d | 30.9 ± 0.2 a | 91.01 ± 1.7 e | |
| 75 | 35.1 ± 0.4 e | 27.4 ± 1.0 bc | 95.02 ± 0.8 d | ||
Figure 6Microbial count of control (unprocessed), pasteurized and HIUS processed melon (Cucumis melo) juice: (a) aerobic bacterial count, (b) coliforms, (c) molds and (d) yeasts. Different letters above the bars indicate statistical difference in treatments (p < 0.05) (n = 3).